Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sagimet Biosciences Inc.

3.59
-0.2400-6.27%
Post-market: 3.590.00000.00%19:31 EDT
Volume:433.97K
Turnover:1.55M
Market Cap:115.58M
PE:-2.47
High:3.79
Open:3.79
Low:3.50
Close:3.83
Loading ...
Jul 02, 2024

Major Issues Report

Form 8-K - Current report
Jun 13, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
May 23, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2024

Major Issues Report

Form 8-K - Current report
Mar 25, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 25, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2024

Major Issues Report

Form 8-K - Current report
Jan 30, 2024

Major Issues Report

Form 8-K - Current report
Jan 24, 2024

Major Issues Report

Form 8-K - Current report
Jan 24, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 24, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933